Neko Health Secures $700M Series C for US Expansion and Advanced Preventive Health Technology

350,000 people have joined the waitlist or registered for a Neko Health Scan, indicating a larger demand base than the 100,000+ figure cited in the summary.
The Stockholm clinic is built around the next-generation devices Derma-2, Echo-2 and Spectrum-2, with Neko planning to roll the hardware upgrade out across all clinics in the coming months.
Each Neko Health Scan uses more than 70 sensors to collect about 50 million data points, underscoring the device-rich, high-resolution data approach.
The service reports an approximately 80% retention rate, with many patients prepaying for their next annual scan, highlighting strong repeat engagement.
The Series C round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, with participation from existing investors Atomico, General Catalyst and Lakestar, plus new backers Liberty City Ventures, Positive Sum and BDT & MSD.
Neko Health has raised $700 million in a Series C round to fund its first U.S. clinic and build out its network of preventive health scan centers. The Stockholm-based startup, co-founded by Spotify creator Daniel Ek and Hjalmar Nilsonne, is now valued at over $5 billion, according to Tech.eu.
The round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners. Existing backers Atomico, General Catalyst, and Lakestar returned, joined by new investors Liberty City Ventures, Positive Sum, and BDT & MSD, Tech.eu reported.
A Neko Health Scan takes 60 minutes and uses more than 70 sensors to collect around 50 million data points. The scan is non-invasive and radiation-free. It includes blood analysis and ends with an in-person review from a doctor on-site. Patients get their results the same day, according to HT World.
The scan costs £299 in the UK and 2,750 SEK in Sweden. Neko has clinics in London, Manchester, Birmingham, and Stockholm. Over 350,000 people have joined the waitlist or signed up for a scan. More than 100,000 scans have already been completed across the UK and Sweden, Business Cloud reported.
Neko's Stockholm clinic now runs on a new suite of hardware: the Derma-2, Echo-2, and Spectrum-2. These are the company's next-generation scanning devices, built entirely in-house. Neko plans to roll out this hardware upgrade across all its clinics in the coming months, according to Tech.eu.
The company builds all its hardware and software itself. That in-house approach gives Neko full control over how its devices work and how patient data is handled. Investors see this as a key advantage in a market where most health tech firms rely on outside vendors.
Neko reports an 80% retention rate. Many patients prepay for their next annual scan before they even leave the clinic. That kind of repeat engagement is rare in health tech, where one-time visits are common, Business Cloud noted.
The waitlist of 350,000 people also points to demand that far outpaces current supply. Neko's US launch, expected later this year, is designed to start closing that gap, Mix 92.9 reported.
The fundraise is one of the largest ever for a European health tech startup. It reflects growing investor appetite for proactive, data-driven care — the idea of catching health problems early, before they become serious. Neko's model centers on annual scans rather than reactive doctor visits, according to HT World.
Neko's first U.S. clinic is set to open later this year. The $700 million will fund that launch, new clinic buildouts, and continued R&D. With a waitlist already in the hundreds of thousands and a retention rate of 80%, the company heads into the U.S. market with momentum behind it, WKZO reported.
Publishers
28
Articles
74
Reach
102